Keynote Speakers
Sekar Kathiresan, MD
Chief Executive Officer, Founder, Verve Therapeutics
Bev Davidson, PhD
Professor of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania/Children’s Hospital of Philadelphia
David R. Liu, PhD
Richard Merkin Professor and Director of the Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Thomas Dudley Cabot Professor of the Natural Sciences at Harvard University, and Investigator of the Howard Hughes Medical Institute
Speakers
Daniel Bauer, MD, PhD
Gene Therapy Program Director, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center | Donald S. Fredrickson, MD Associate Professor of Pediatrics, Harvard Medical School | Principal Faculty, Harvard Stem Cell Institute | Associate Member, Broad Institute
Laura Sepp-Laurenzino, PhD
Chief Scientific Officer, Executive Vice President
Intellia Therapeutics
Nicole Gaudelli, PhD
Director, Head of Gene Editing Platform Technologies
Beam Therapeutics
Christoph Bock, PhD
Principal investigator, Research Center for Molecular Medicine of the Austrian Academy of Sciences
Kristin Knouse, MD, PhD
Assistant Professor of Biology; Intramural Faculty, Koch Institute
MIT
Mathew Garnett, PhD
Senior Group Leader
Wellcome Sanger Institute
Samuel Sternberg, PhD
Principal Investigator, Assistant Professor
Department of Biochemistry and Molecular Biophysics
Columbia University
Cecilia Cotta-Ramusino
Senior Vice President of Technology Development at Tessera, Senior Fellow at Flagship Pioneering
James Dahlman
McCamish Foundation Early Career Professor, Associate Professor
Department of Biomedical Engineering
Georgia Tech and Emory University
